iiinova — where your digital self keeps evolving

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 01/06/2025

Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!! Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone. Fewer hot flashes 🥵, more dizziness 😵‍💫

040

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 01/06/2025

Studies of HRT in breast cancer coming in 🔥🔥🔥 #ASCO25!!@ascocancer.bsky.social 🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life. Sets the stage for more studies of CE/BZA in #bcsm

010

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 31/05/2025

VERITAC-2: Vepdegestrant showed improved progression free survival in metastatic breast cancer with ESR1 mutation 🧬 As a community oncologist, thrilled that we could offer this trial to our patients close to their homes 🏠 and now see it published today in @nejm.org and presented at #ASCO25 #bcsm

060

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 31/05/2025

Impressive overall survival benefit with the addition of inavolisib to palbo-fulvestrant in PIK3CA mutated 🧬 HR+ metastatic breast cancer in the INAVO120 study published in @nejm.org today and presented at #ASCO25 ⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects #bcsm @oncoalert.bsky.social

051

Reposted by Laila Agrawal, MD IF

Gregory Riely @rielymd.bsky.social · 31/05/2025

Great presentation by Dr Bauman at #ASCO25 highlights that there are many ways patients make decisions, with different priorities for their care.

042

Reposted by Laila Agrawal, MD IF

Stacey Tinianov, MPH @coffeemommy.bsky.social · 31/05/2025

Kicked off Day 2 of #ASCO25 with coffee in the Advocate Lounge Now looking forward to this session on facilitating informed discussions around evidence-based supportive care

2134

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 30/05/2025

Fantastic chapter on digital media highlighting benefits and pitfalls of tools like social media and AI

010

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 24/05/2025

Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.

020

Laila Agrawal, MD IF @lailaagrawalmd.bsky.social · 24/05/2025

So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡

032

Reposted by Laila Agrawal, MD IF

The OncoAlert Network 🚨 @oncoalert.bsky.social · 23/05/2025

The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸 @elisaagostinetto.bsky.social‬ @erikahamilton9.bsky.social‬ @drsgraff.bsky.social‬ @elisabettabonzano.bsky.social‬

0128

Reposted by Laila Agrawal, MD IF

Betty Roggenkamp @bettyroggenkamp.bsky.social · 21/05/2025

This 👇🏾 is for every #oncology clinician who treats #AYA. Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al #AYACSM #sexualhealth #lateandlongterm

031

Reposted by Laila Agrawal, MD IF

Stephanie L. Graff, MD FACP FASCO @drsgraff.bsky.social · 07/04/2025

Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy: A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared. Preach! 🙌🏻 🗣️ @ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social

062